top of page

Item List

Invitae and Simons Searchlight Partner to Accelerate Research through Data Sharing

Invitae (NYSE: NVTA), a leading medical genetics company, today announced a collaboration with Simons Searchlight, an international research program with a goal of accelerating research and improving lives for people with rare genetic neurodevelopmental disorders. This partnership will connect two sets of data – the longitudinal clinical data extracted from medical records through Invitae's Ciitizen, a patient-consented, digital natural history data platform and patient reported outcomes and biospecimens collected by Simons Searchlight. The partnership breaks down data silos and provides a rich and deep dataset that will help accelerate research for rare neurodevelopmental diseases.

Recent Posts

Wavemaker 360 News


Episode 108: Jay Goss, General Partner at Wavemaker Three-Sixty Health ...

MedTech Money

Portfolio Company


Strados Labs forms collaboration with Boehringer Ingelheim for its Idiopathic Pu ...

Cision PR Newsire

Portfolio Company


Caduceus Capital Partners, Wavemaker Three-Sixty Health Co-Lead Series A Investm ...


surf break copy_edited_edited.jpg
bottom of page